
    
      -  Taxotere, cisplatin and irinotecan will be administered to the patient once weekly for 2
           weeks followed by a one week rest period (1 cycle is 3 weeks).

        -  Patients will also receive corticosteroids, intravenous hydration and anti-emetic
           therapy prior to each treatment.

        -  A physical exam and bloodwork will be done each week of the treatment and every 2
           cycles, reassessment of the tumor by the same imaging method to determine the baseline
           size will be conducted.

        -  Patients will remain on the study unless disease progression or intolerable toxicity
           occur.
    
  